Stanford University is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Location
Stanford, California, USA
Type
Private Research University
Website
[stanford.edu](https://www.stanford.edu)
Stanford University is a leading research institution with extensive programs in neuroscience and neurodegenerative disease research. The Stanford School of Medicine and Stanford Neuroscience Institute coordinate interdisciplinary research across departments.
The Stanford Neuroscience Institute brings together over 200 faculty members across 40+ departments to study brain function and neurological disorders.
- Stanford Alzheimer's Disease Research Center: Clinical and basic research
- Center for Memory Disorders: Clinical care and research
- Banner Stanford Alzheimer's Center: Translational research
- Stanford Parkinson's Disease Research Center: Motor and non-motor symptoms
- Lewy Body Dementia Program: DLB and PDD research
- Protein aggregation mechanisms
- Stem cell and iPSC models
- Neuroimaging and biomarkers
- Deep brain stimulation
- Gene therapy approaches
- Neuroimmunology
- Alpha-synuclein propagation mechanisms
- LRRK2 kinase function and inhibition
- iPSC models of Parkinson's disease
- Novel immunotherapy approaches
- Tau oligomer characterization
- Neural circuit dysfunction in movement disorders
¶ Major Labs and Centers
| Lab/Center |
Focus |
Key Faculty |
| Bezprozvanny Lab |
Calcium signaling |
Ilya Bezprozvanny |
| Luo Lab |
Synaptic function |
Jun Ding |
| Shen Lab |
Parkinson's disease |
Jing Wang Shen |
| Zhang Lab |
Stem cells |
Marius Wernig |
| Palop Lab |
Network dysfunction |
Jorge Palop |
- Stanford Brain Imaging Center: MRI and PET imaging
- Stanford Neuroscience Cell Imaging Core: Microscopy and imaging
- Genome Technology Center: Genomics and proteomics
- Human Immune Monitoring Core: Immunology studies
Stanford offers comprehensive training in neurodegeneration:
- Neuroscience PhD program
- Neurology residency and fellowships
- Postdoctoral training programs
- Summer undergraduate research programs
Stanford houses the Stanford Neuroscience Institute, the Alzheimer's Disease Research Center, the Wu Tsai Neurosciences Institute, and the Molecular and Cellular Physiology Department. The Stanford Stroke Center provides clinical research opportunities.
Stanford offers PhD programs through the School of Medicine with over 1,000 graduate students. The neuroscience program is among the most competitive in the world, admitting approximately 15-20 students per year.
The study of Stanford University has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Luk KC, et al. (2012). Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. PMID:23100461
- Wernig M, et al. (2008). Reprogramming of fibroblasts into functional neurons by defined factors. Nature. PMID:18362901
- Bezprozvanny I. (2010). Calcium signaling and neurodegenerative diseases. Trends Mol Med. PMID:20071232
- Zhang Y, et al. (2013). Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron. PMID:23769911
Stanford offers extensive training opportunities in neurodegenerative disease research:
- Neuroscience PhD Program: Comprehensive training in cellular, molecular, and systems neuroscience
- Neurology Residency: ACGME-accredited program with research track
- Postdoctoral Training: Over 50 postdoctoral positions in neuroscience labs
- Medical Student Research: NINDS-funded summer research program
- Clinical Fellowships: Alzheimer's, Parkinson's, and movement disorders fellowships
- Multiple trainees have received NIH K99/R00 and F32 awards
- Several trainees have published first-author papers in high-impact journals
- Alumni have gone on to faculty positions at major research institutions
Stanford maintains active international collaborations in neurodegeneration research:
- Michael J. Fox Foundation: PD research consortium
- Alzheimer's Association: International research network
- Genes Without Borders Initiative: Global genetics collaboration
- European Parkinson's Disease Association: Joint clinical trials
- Asian Neuroscience Consortium: Stem cell therapy research
- International Parkinson's Disease Genetics Consortium
- Global Alzheimer's Association Interactive Network
- Tau Consortium
Stanford is positioning itself for future breakthroughs in neurodegeneration:
- Single-cell genomics: Characterizing cell-type specific vulnerabilities
- Spatial transcriptomics: Mapping gene expression in brain tissue
- Organoid models: Human-derived brain models for drug testing
- Gene editing: CRISPR approaches for genetic forms of neurodegeneration
- Expansion of the Stanford Neuroscience Institute facilities
- New endowed chairs in neurodegeneration research
- Increased industry partnerships for drug development
- Clinical trial infrastructure enhancement